Chemicals

N,N,N’,N’-tetrakis(2,3-epoxypropyl)-m-xylene-α,α’-diamine Cas:63738-22-7

We are N,N,N’,N’-tetrakis(2,3-epoxypropyl)-m-xylene-α,α’-diamine CAS:63738-22-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

N,N,N',N'-tetrakis(2,3-epoxypropyl)-m-xylene-α,α'-diamine

Synonyms：

N,N,N',N'-Tetraglycidylbenzene-1,3-bis(methaneamine)1,3-Benzenedimethanamine,N,N,N,N-tetrakis(oxiranylmethyl)n,n,n',n'-tetrakis(oxiranylmethyl)-3-benzenedimethanamine1,3-Bis[(diglycidylamino)methyl]benzeneN,N,N',N'-Tetraglycidyl-1,3-benzenebis(methanamine)EPICHLOROHYDRIN-METOXYLYLENEDIAMINE REACTION PRODUCTSm-Phenylenebis(diglycidylaminomethane）N,N,N',N'-Tetraglycidyl-1,3-benzenedi(methanamine)1,3-Phenylenebis(N,N-diglycidylmethaneamine)N,N,N',N'-Tetrakis(oxiranylmethyl)-1,3-benzenedimethanamine

molecular formula: C20H28N2O4

Molecular weight:360.44700

Physical Properties:

Density: 1.27g/cm3

Boiling point: 487.1ºC at 760 mmHg

Flash point: 140.6ºC

Refractive index: 1.602

Specification:

Items of Analysis	Standard of Analysis	Test Results
Appearance	Light yellow transparent liquid	Conform
Epoxy value, /100g	0.90-1.06	0.984
Non-volatile matter, %	≥98.5	99.26
Viscosity (25±1℃) , mPa·s	1500-3000	2200
Conclusion	Conforms to Factory Standard

Application:

It can be used as a high temperature resistant main resin and a high temperature resistant epoxy diluent. It can be used as a special diluent for high viscosity epoxy systems. At the same time, this diluent has superior high temperature resistance and can reduce the impact on the temperature resistance of the system compared with ordinary diluents.

Package and Storage:

1kg/bottle, 20kg/drum.

Market News:providing support for flexible, cross-sector training programmes to encourage more movement and collaboration between academia, industry and the charity sector 5-methyl-thiophene-2-carboxylic acid [5-(3-ethoxy-phenyl)-8-methoxy-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-amide manufacturer.“This announcement reflects another important regulatory milestone in the development of this medicine,” said Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories. (pentamethylcyclopentadienyl)Ru(η(2)-O2CMe)(PPh3) supplier.Both were randomised, double-blinded, placebo-controlled trials in patients with moderate to severe autoantibody-positive SLE who were receiving standard therapy. 4,5-dihydroxy-1-(4-((3-hydroxy-13,24,34,43,53,63-hexaoxin-2-yl)tetraoxidaneyl)-13,24,33,44,53,63-hexaoxin-2-yl)-14,44,54-hexaoxid-4-en-1-one producer.

Product Name
Mesterolone Cas:1424-00-6	View Details
di-tmpta Cas:94108-97-1	View Details
dibenzo-18-crown-6 Cas:14187-32-7	View Details